Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

ASNC Commits to Patient-Centered Care

The 16th annual scientific session of the American Society of Nuclear Cardiology (ASNC), Sept. 8-11, brings together scientists, clinicians and industry to establish and discuss optimal standards of imaging care.

Toshiba MRI Scanner Garners FDA Approval

Toshiba today announced that it has received Food and Drug Administration (FDA) clearance for its Vantage Titan™ 3T open-bore MRI scanner.

Dynamic Contrast-Enhanced Ultrasound Enhances Microvascular Perfusion Deficit Detection

Microvascular perfusion deficits and reduced arterial perfusion reserve are clearly detectable in patients with peripheral arterial disease (PAD) when dynamic contrast-enhanced ultrasound (CEUS) is used after transient arterial occlusion, report the authors of a feasibility study published online and in the August issue of Investigative Radiology.

AJR: A molecular theranostics primer

Molecular theranostics holds promise, offered a review published in the August issue of American Journal of Roentgenology.

Varian's Aria Receives ONC-ATCB EMR Certification

Varian Medical Systems (NYSE: VAR) of Palo Alto. Calif. yesterday announced that its ARIA® software for electronic medical records (EMR) and clinical practice management in radiation oncology has been certified for clinics that can now use it to qualify for federal funding under the U.S.HITECH Act.

Siemens Gets FDA Nod For First Hybrid PET/MRI Scanner

Marking the debut of the first equipment to enable simultaneous whole-body acquisition of data from magnnetic resonance (MR) and positron emission tomography (PET), Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biograph mMR hybrid PET/MRI scanner.

Study Confirms Safety Of Ultrasound Contrast Agent

Optison ™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent designed by GE Healthcare to improve suboptimal echocardiograms, may be used without concern about its affects on pulmonary arterial systolic pressure (PASP) or pulmonary vascular resistance (PVR), according to results of a study

Storage Management and Planning in the EMR Era

Health IT professionals have had their hands full in recent months, scrambling to understand how best to meet the provisions of meaningful use in order to capitalize on American Recovery and Reinvestment Act incentives—and, eventually, to avoid CMS payment penalties. One area affected by meaningful use that often goes unconsidered, however, is